Astellas Pharma Inc.

Pharmaceuticals
Japan
Executive 1Masafumi Nogimori, Chairman; | Chairman;
Executive 2Yoshihiko Hatanaka, President; | Senior Vice President;
Earnings Per Share Growth (%)52.02%
Cost of Goods Sold (US$ Millions)$2,793
Current Liabilities (US$ Millions)$3,528
Total Assets (US$ Millions)$8,096
Long Term Debt (Millions)N/A
Return on Equity10.71%
Revenue (US$ Millions)$10,547
Total Company Assets$15,033
Revenue Growth (%)10.26%
Net Income (US$ Millions)$1,139
Earnings Per Share (US$)$0.51
Total Equity (US$ Millions)$11,046
Profit Margin (%)10.80%
Debt To Equity Ratio (%)N/A
Inventories (Millions)$1,315